|
Originally published In Press as doi:10.1074/jbc.M109465200 on December 17, 2001
J. Biol. Chem., Vol. 277, Issue 10, 8395-8405, March 8, 2002
Up-regulation of Acid-gated Na+ Channels (ASICs) by
Cystic Fibrosis Transmembrane Conductance Regulator Co-expression
in Xenopus Oocytes*
Hong-Long
Ji ,
Biljana
Jovov ,
Jian
Fu §,
LaToya R.
Bishop ,
Hannah C.
Mebane ,
Catherine M.
Fuller ,
Bruce A.
Stanton¶, and
Dale J.
Benos
From the Department of Physiology and Biophysics,
University of Alabama, Birmingham, Alabama 35294 and
¶ Department of Physiology, Dartmouth Medical School,
Hanover, New Hampshire 03755
Received for publication, October 1, 2001, and in revised form, November 19, 2001
 |
ABSTRACT |
Cystic fibrosis transmembrane conductance
regulator (CFTR) functions as both a chloride channel and an epithelial
transport regulator, interacting with Na+ (epithelial
sodium channel), Cl , renal outer medullary
potassium channel+, and H2O channels and some
exchangers (i.e. Na+/H+) and
co-transporters
(Na+-HCO ,
Na+-K+-2Cl ). Acid-sensitive ion
channels (ASICs), members of the epithelial sodium
channel/degenerin superfamily, were originally cloned from neuronal tissue, and recently localized in epithelia. Because CFTR has
been immunocytochemically and functionally identified in rat, murine,
and human brain, the regulation of ASICs by CFTR was tested in oocytes.
Our observations show that the proton-gated Na+ current
formed by the heteromultimeric ASIC1a/2a channel was up-regulated by
wild type but not by F508-CFTR. In contrast, the acid-gated
Na+ current associated with either the homomultimeric
ASIC1a or ASIC2a channel was not influenced by wild type CFTR. The
apparent equilibrium dissociation constant for extracellular
Na+ for ASIC1a/2a was increased by CFTR, but CFTR had no
effect on the gating behavior or acid sensitivity of ASIC1a/2a. CFTR
had no effect on the pH activation of ASIC1a/2a. We conclude that wild
type CFTR elevates the acid-gated Na+ current of ASIC1a/2a
in part by altering the kinetics of extracellular Na+ interaction.
 |
INTRODUCTION |
Hyperactivated Na+ absorption through epithelial
sodium channel (ENaC)1 is
important in the pathophysiology of cystic fibrosis (CF (1-5)). The
idea that the cystic fibrosis transmembrane conductance regulator (CFTR) may function as a regulator of ENaC has been tested in systems
co-expressing CFTR and ENaC (6-8). Those studies demonstrated that
wild type but not mutant CFTR expression functionally down-regulates ENaC, and ENaC stimulates the activity of CFTR (8-10). Also, defective Na+ absorption is restored by CFTR replacement therapy
(11). Mutagenesis studies show that the cytoplasmic regulatory domain
of CFTR and the cytosolic C termini of - and -ENaCs contribute to
the functional and physical intermolecular interactions between CFTR
and ENaC (8, 10). Because the sulfonylurea receptors, a branch of the
family of ATP binding cassette (ABC) transporter proteins, show a high
degree of homology with CFTR, Konstas et al. (12) studied
the interaction between sulfonylurea receptors and ENaC. They concluded
that sulfonylurea receptors inhibit Na+ transport by
reducing surface expression of ENaC, but there is no protein-protein
interaction at the level of the plasma membrane. Although several
mechanisms have been proposed to explain the interaction between CFTR
and ENaC, they have not yet been systematically tested (13-16).
A new subfamily of the ENaC/DEG superfamily, the acid-sensing ionic
channels (ASICs), has recently been identified (17). Like other family
members, ASICs are thought to have a single, large extracellular loop,
and two short transmembrane domains with both the C and N termini
located intracellularly (17). ASICs are ligand-gated ion channels
activated by extracellular acidification and perhaps mechanical
stimulation. The biophysical and pharmacological characteristics of
ASICs are similar to those of ENaC, albeit with a lower sensitivity to
amiloride (Ki ~ 10 µM
versus 0.1 µM) and a different cation
permeability pattern (17). However, the acid-gated cation current is
transiently (seconds) activated and inactivated, whereas ENaC current
decreases at extracellular pH 6.4 after a transient increase (18).
Likewise, the native amiloride-sensitive Na+ conductance is
activated by slightly acidic pHe (5.5 or 6.4) in toad bladder
and A6 cells (18, 19). ASIC members, like ENaC, may assemble as a
tetramer or as a higher order heteromultimeric channel (20). The
biophysical features of heteromultimeric channels constructed with
ASIC1a and ASIC2a (ASIC1a/2a) or ASIC2b with ASIC3 (ASIC2b/3) can be
distinguished from those built from homomultimeric individual channels
(21, 22). ASIC1a (23, 24), ASIC2a (21, 23, 25-28), and ASIC2b (21)
show a wide-spread distribution in the brain. ASIC1a, ASIC1b (29),
ASIC2b, and ASIC3 (30, 31) have been localized to dorsal root ganglion
sensory neurons. However, CFTR expression has not been reported in the
peripheral neuronal tissues. Human ASIC3 is distributed in both
neuronal tissues and epithelial tissues (32), and a splice variant
(hTNaC1) was cloned from human testis (33). The most recently
discovered homolog, ASIC4, has been found in the spinal cord, the
pituitary gland, and the inner ear (34, 35). The distribution of ASIC members thus extends beyond the central nervous system.
CFTR has been immunocytochemically and electrophysiologically
identified in rat brain (36-40), human hypothalamus (41), and a murine
neuronal cell line established from the hypothalamus (42). In these
same groups of neurons where CFTR is found, ASIC1a and ASIC2a are also
expressed (17). The function of neuronal CFTR remains unknown. It is
proposed that neuronal CFTR may regulate membrane trafficking processes
of cytoplasmic ionic transporters and secretion of neuropeptides (42).
Decreased CFTR expression in GT1-7 hypothalamic neurons produced by
antisense against CFTR mRNA inhibits gonadotropin-releasing hormone
secretion (42). Gonadotropin-releasing hormone has been postulated to
be related to the infertility and delayed sexual maturation of CF
patients in a developmentally sensitive pattern (42, 43). ASICs may act
as pain sensors, mechanical receptors, and/or components of a signal
transduction pathway responding to extracellular acidity.
To investigate the possible functional regulation by neuronal CFTR on
ASIC1a/2a, the objective of the present study was to use
Xenopus oocytes as an expression model to study the effect of human CFTR on the channel activity of ASIC1a/2a. Our results show
that CFTR up-regulates proton-gated Na+ currents by
altering the kinetics of extracellular Na+ interaction with
ASIC1a/2a.
 |
EXPERIMENTAL PROCEDURES |
cRNA Preparation--
Full-length human ASIC1a (BNaC2) and
ASIC2a (BNaC1) cDNAs and their "degenerin" mutants were kind
gifts of Drs. D. Corey and J. García-Añoveros (Harvard
Medical School (23)). DNA samples were in vitro transcribed
using either SP6 or T3 mMessage Machine kits (Ambion, TX) as
appropriate. The quality and size of the cRNAs were confirmed by
denaturing formaldehyde-agarose gel electrophoresis. RNA concentration
was estimated by UV spectrophotometry at a wavelength of 260 nm.
Immunofluorescence of Rat Hypothalamus--
Expression of ASIC2a
and CFTR in the rat hypothalamus was stained by indirect
immunofluorescence. Rats were anesthetized with halothane, perfused
transcardially with 60 ml of ice-cold phosphate-buffered saline, and
followed by 60 ml of ice-cold 4% paraformaldehyde. This protocol was
reviewed and approved by the University of Alabama at Birmingham
Institutional Animal Use and Care Committee. The brains were then
removed from the skull, post-fixed in the same fixative for 2-4 h on
ice, and cryoprotected by overnight immersion in 30% sucrose in
phosphate-buffered saline. Tissue samples were embedded in optimal
cutting temperature compound (Sakura Finetek, Torrance, CA)
medium, then 5-µm frozen sections were obtained. The sections were
incubated with the primary antibody solution for 72 h at 4 °C
with 5% normal goat serum and 0.1% Triton X-100. Rat brain tissue
sections were labeled with one or two of the following antibodies: a
1:50 dilution of polyclonal anti-CFTR antibodies (44); a 1:20 dilution
of monoclonal anti-CFTR antibody (45); or a 1:20 dilution of polyclonal
anti-ASIC2a antibodies (Alamone, Jerusalem, Israel). The identity of
the stained cells as neurons was established using co-staining with a
1:20 dilution of neuron-specific nuclear monoclonal antibodies NeuN
(CHEMICO International, Temecula, CA). The samples were rinsed in
phosphate-buffered saline and exposed to the secondary antibody
solution, goat anti-rabbit-Alexa 594 for ASIC2a and NeuN (1:200,
Molecular Probes, Eugene, OR), or goat anti-mouse-Alexa 488 for CFTR
(1:200, Molecular Probes) for 2 h at room temperature. Samples
were rinsed in phosphate-buffered saline, mounted, and examined using
an Olympus 1 × 70 epifluorescence microscope. Nonimmune IgG and
the secondary antibodies were used as controls. The distribution of
ASIC1a was not examined because of a lack of a suitable antibody.
Oocyte Preparation--
Oocytes were surgically removed from
anesthetized adult female Xenopus laevis (Xenopus Express,
Beverly Hills, FL) by standard techniques (46). Follicle cells were
removed in OR-2 calcium-free medium (82.5 mM NaCl, 2.4 mM KCl, 1.0 MgCl2 mM , 5.0 mM Na-HEPES, pH 7.5) with the addition of collagenase (3 mg/ml). Defollicated oocytes were washed in OR-2 medium to which 50 mM CaCl2 was added and allowed to recover
overnight in half-strength Teibovitz medium at 18 °C. Groups of
stage VI oocytes were injected with 50 nl of RNase-free H2O
or cRNA containing 2.5 ng of CFTR cRNA and 12.5 ng of ASIC cRNA.
Two-electrode voltage clamp measurements were made 24-72 h
post-injection at room temperature (22-24 °C). This protocol was
reviewed and approved by the University of Alabama at Birmingham
Institutional Animal Use and Care Committee.
Electrophysiological Recordings--
Whole-cell proton-gated
Na+ currents were measured in oocytes expressing ASICs and
CFTRs with conventional dual electrode voltage clamps as described
previously (46). Oocytes were impaled with two 3 M
KCl-filled electrodes, each having resistances of 0.5-1.5 M . The
virtual current monitor/bath clamp head stage of the Dagan TEV-200
whole-cell clamp monitors the macroscopic currents flowing through the
oocyte and simultaneously maintains the bath at zero potential. This
head stage corrects for voltage deviations introduced by current flow
through the reference electrode and agar bridge so that oocyte current
can be recorded precisely without the series resistance compensation.
Two chlorinated Ag-AgCl pellets (1 mm in diameter), each with a
resistance below 500 , were used as reference electrodes and were
connected to the bath by 3 M KCl, 3% agar bridges
(resistance was ~200 ). The control superfusate was ND96 (96 mM NaCl, 1 mM MgCl2, 1.8 mM CaCl2, 2 mM KCl, and 5 mM HEPES, pH 7.5). To prepare ND-96 medium with pH below
6.0, HEPES was replaced with MES. Equimolar concentrations of
N-methyl-D-glucamine were used to replace
NaCl in those experiments where the [Na+]o was
varied. To allow the ASIC channels to recover completely from
de-sensitization after bath solution acidification, solutions of acidic
pH were applied for a period of 10 s separated by an interval of
at least 45 s at pH 7.5. The current-voltage (I-V) relationships
were acquired by stepping the holding potential in 20-mV increments
from 100 to +100 mV. The effects of bath solution acidification (pH
4.0) on the resting membrane potential were recorded, and acid-gated
Na+ entry through ASICs was measured. Data for voltage and
current clamps were sampled at the rate of 1 kHz and filtered at 500 kHz. Experimental protocols were controlled by pCLAMP 8.2 software (Axon Instruments, Burlingame, CA), and Na+ currents at
60 mV were digitized and stored on the hard drive of a computer for
later analysis.
Data Analysis--
All macroscopic currents presented in this
paper are proton-activated Na+ currents. The maximal inward
or outward current activated by low pHe was measured and
referred to as the transient peak current (Ip, nA).
Ip usually occurred within 500~1000 ms after the
change in pHe. The relatively stable current was measured
8 s after the application of acidic pHe and is referred to
as the sustained current (Is, nA). The inactivation
time constant ( i, ms) was calculated by fitting the time
course of current decay subsequent to peak current according to the
equation,
|
(Eq. 1)
|
where A stands for the current amplitude,
i is the inactivation time constant, C is the
basal current recorded at pH 7.5 for each component i, and
t is the time period of the recording. The inactivating
current (from the peak current to 8 s) was fit to a first order
exponential. Determination of i is depicted in Fig.
2B.
Computation of the EC50 of the external proton
concentration
(pH ) was
performed by fitting both the acid-gated peak current and the sustained currents as a function of external pH with the Hill equation,
|
(Eq. 2)
|
where INa is the proton-gated currents,
Imax is the maximal acid-gated current,
pHe stands for the extraoocyte pH, EC50 represents
the value of pHe, which results in half of the maximal current
of the ASIC channel, and n is the Hill coefficient. To
further verify the calculation, the Hill coefficient and
EC50 were also computed by fitting the normalized
acid-gated Na+ currents with the equation,
|
(Eq. 3)
|
where [H+]e is the proton concentration in
the bath solution.
To analyze the steady-state kinetics for proton-activated
Na+ current as a function of bath solution
[Na+], superfusates containing variable concentrations of
Na+ (ranging from 0 to 96 mM) were sequentially
superfused into the chamber. Km and
Imax were calculated by fitting the proton-gated Na+ currents against the concentration of extracellular
Na+ with the Michaelis-Menten equation,
|
(Eq. 4)
|
where Km is the concentration required for
activating half of the maximal current, Imax and
INa are the proton-gated currents, and [Na]
represents the extraoocyte concentration of sodium. A nonlinear curve
fitting subroutine was applied to fit the data.
All results are presented as the mean ± S.E. Student's
t test was used to compare means. A probability level of
0.05 or less was considered significant.
 |
RESULTS |
CFTR Co-localizes with ASIC2a--
ASIC2a and CFTR were detected
in rat anterior hypothalamus by indirect immunofluorescence (Fig.
1). Control sections labeled with
nonimmune IgG and secondary antibodies did not reveal any staining (not
shown). CFTR is expressed in long cellular processes, most likely
dendrites (Fig. 1, top panel). ASIC2a is expressed in
punctate regions, most likely cell bodies of neurons (Fig. 1B, middle panel). Double-labeling with anti-CFTR
and anti-ASIC2a antibodies revealed that CFTR is primarily expressed in
a sub-population of neuronal cells expressing ASIC2a (Fig. 1,
bottom panel). Some co-localization is also observed in
neuronal cellular processes. Similar patterns of co-localization have
also been observed in the hippocampus (not shown).

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 1.
Co-localization of ASIC2a and CFTR in rat
hypothalamus. All panels represent epifluorescent images taken
from sagittal sections of the rat hypothalamus. A, top
panel, CFTR was stained using monoclonal anti-CFTR antibodies.
CFTR-labeled sub-population of neuronal cells and their processes is
shown. B, middle panel, ASIC2a was stained using
commercially available polyclonal anti-ASIC2a antibodies. ASIC2a
strongly labeled cells bodies in the same region of hypothalamus.
C, bottom panel, double staining with anti-CFTR
and anti-ASIC2a antibodies overlap in sub-population of neuronal cell
bodies and processes.
|
|
CFTR Activates Acid-gated Currents--
To avoid any current from
endogenous hyperpolarization-activated ion channels, which are
activated at membrane potentials more hyperpolarized than 140 mV
(47), the exogenous acid-gated Na+ currents associated with
ASICs were obtained while oocytes were clamped at 60 mV. Reduction of
pHe (4.0) had no effect on INa in
water-injected oocytes (Figs. 2 and
3).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Activation of ASICs by external acidic
pH. A, representative acid-gated Na+
current at holding potential of 60 mV in an oocyte. The solid
line above the trace shows the period of acidic pH
application (10 s). B, representative inward Na+
current in an oocyte expressing ASIC1a/2a. The distance indicated by
the left pair of arrows is the time to
peak current (see "Experimental Procedures"). The dotted
line overlapped on the trace was produced by fitting the component
of the de-sensitization current with a first order exponential decay
function to compute the inactivation time constant ( i).
C, representative acid-induced Na+ current in an
oocyte co-expressing ASIC1a/2a and CFTR. D, representative
acid-gated Na+ current in an oocyte expressing ASIC1a/2a
and F508-CFTR. These whole cell current traces were recorded from
oocytes isolated from the same frog and at the same time point (48 h)
after cRNA injection. These experiments were repeated more than 5 times. The scale bars for the x axis (2 s) and
y axis (5 µA) are applied to all four panels.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Up-regulation of acid-gated conductance
associated with the heteromultimeric ASIC1a/2a channel by CFTR
co-expression. A, I-V relationship of peak current. The
proton-gated transient Na+ currents
(I ) for the heteromultimeric
ASIC1a/2a channel alone (circles) and co-expressed with CFTR
(squares) were evoked at membrane potentials
(Vm) ranging from 100 mV to +100 mV. The
macroscopic conductances are linear for both groups with reversal
potentials of about +30 mV. B, corresponding I-V curve of
sustained current (I ).
Reversal potentials were ~7 mV for ASIC1a/2a and 10 mV for CFTR and
ASIC1a/2a as indicated by the arrows. C, average
macroscopic currents of the transient Na+ currents
(I ) in water-injected oocytes
(H2O) with (ASIC1a/2a + CFTR) and without CFTR
co-expression (ASIC1a/2a). D, corresponding whole-cell
sustained Na+ currents
(I ) evoked by pH 4.0 at a
holding potential of 60 mV for H2O, ASIC1a/2a, and
ASIC1a/2a + CFTR. n stands for the number of cells.
|
|
In oocytes expressing ASIC1a/2a, a reduction in pHe (4.0)
transiently activated an inward Na+ current. The current
peaked (Ip) and then decayed exponentially to a
value close to basal (unstimulated) values (Fig. 2B). The transiently
activated Na+ current associated with ASIC1a/2a generally
reached its peak in 500 ms or less (Ip) after
switching the pHe to 4.0 from 7.5. However, the acid-gated
Na+ current took 1000 ms or more to become sustained
(Is). The de-sensitized current fits to a first
order exponential decay. The acid-gated sustained Na+
current (Is) was measured 8 s after acidic
pHe application. The characteristics of acid-gated
Na+ currents described here are consistent with those
demonstrated by a number of other investigators (17, 20-22, 27, 48,
49). CFTR increased the acid-activated Na+ currents
(Ip and Is); however,
F508-CFTR had no effect on Ip and
Is (Fig. 2, C and D).
The current-voltage (I-V) relationships of both Ip
and Is for the heteromultimeric ASIC1a/2a channel
displayed a linear conductance (Fig. 3, A and B).
CFTR co-expression increased the slope conductance of the I-V curves
for Ip, leaving the reversal potential (~30 mV)
unchanged (Fig. 3A). CFTR co-expression also increased the
slope conductance of the I-V curve for Is (Fig.
3B). The reversal potential for Is was
also unchanged by CFTR (Fig. 3B). Ip of
ASIC1a/2a was 6772 ± 985 nA (n = 20) at a
holding potential of 60 mV (Fig. 3C), significantly greater than the current in uninjected oocytes ( 14 ± 17 nA,
p < 0.001). ASIC1a/2a-associated Ip
was up-regulated in oocytes co-expressing CFTR ( 15,554 ± 2,880 nA, p < 0.01) compared with oocytes expressing
ASIC1a/2a alone. Is in the presence of CFTR also
markedly increased to 2217 ± 506 (n = 19) from
624 ± 124 nA (n = 20; p < 0.01, Fig. 3D). In contrast to the up-regulatory effect of
CFTR on ASIC1a/2a, F508-CFTR co-expression did not show a
significant alteration in Ip or
Is (Fig. 2C).
CFTR Co-expression with either ASIC1a or ASIC2a--
Our previous
studies demonstrated that - and -ENaCs were involved in the
cross-talk between CFTR and ENaC (8). In an attempt to identify which
isoform of the heteromultimeric ASIC1a/2a channel was involved in the
intermolecular interaction with CFTR, we co-expressed CFTR with either
ASIC1a or ASIC2a in oocytes. As shown in Fig.
4, CFTR did not increase
Ip or Is produced by ASIC1a clone
or by ASIC2a clone. However, the time to peak current was 1851 ± 414 ms (n = 9), and i was 3613 ± 17 (n = 9) for ASIC1a, slower than those of ASIC2a or
ASIC1a/2a.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 4.
CFTR did not activate ASIC1a or ASIC2a
channels. A, representative acid-activated
Na+ current (pH 4.0) traces in oocytes, from the
left to the right, expressing ASIC1a alone,
ASIC1a co-expressed with CFTR, ASIC2a alone, co-expressed with CFTR.
The holding potential is 60 mV. B, transient macroscopic
Na+ currents (I ).
C, macroscopic sustained currents
(I ).
|
|
To examine the effect of CFTR activation on ASICs, we first tested the
effect of a cAMP-elevating mixture on ASIC1a/2a. After application of
this cAMP-elevating mixture, the normalized Ip decreased to 92 ± 5.1% (n = 5, p > 0.05) of its value before mixture application. In oocytes
co-expressing ASIC1a/2a with CFTR, ASIC1a/2a Ip was
increased by 220 ± 31%. Application of the cAMP-elevating mixture produced a saturation of the CFTR current and did not significantly influence the proton-gated ASIC1a/2a current ( 1665 ± 974 nA without mixture versus 1502 ± 842 nA with
mixture, n = 6, p > 0.05).
CFTR Co-expression on pH Sensitivity of ASIC1a/2a--
To
determine whether CFTR co-expression modified the protonation of
ASIC1a/2a channels, solutions of different external pH were applied to
calculate the pHe required for half-activation of the maximal
conductance (EC50). Current transients for ASIC1a/2a, in
the presence and absence of CFTR, were measured at different solution
pH values (Fig. 5A). CFTR had
no effect on the EC50 for acid activation of ASIC1a/2a
(Fig. 5B). The Hill coefficient was 20.2 ± 3.7 and
22.2 ± 3.7 for ASIC1a/2a alone and ASIC1a/2a + CFTR,
respectively, indicating that protonation of multiple sites is required
for activating ASIC1a/2a. To verify the above findings, we applied the
modified Hill function to the same data (Fig. 5C). The
computed apparent bath pH values at the midpoint of the maximal Na+ current were 5.87, 5.95, and 5.99 in oocytes expressing
ASIC1a/2a alone, ASIC1a/2a with CFTR, and ASIC1a/2a with F508-CFTR,
respectively (n = 9). The same computation was also
applied to the sustained Na+ currents, and nearly identical
EC50 values as those for the peak currents were computed
(data not shown). Thus, there was no difference in ASIC1a/2a
sensitivity to external pH in the presence or absence of CFTR
(p > 0.05).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 5.
Extracellular proton concentration dependence
of Na+ currents. A, proton-induced
Na+ currents in oocytes expressing ASIC1a/2a or
co-expressing ASIC1a/2a + CFTR. B,
pHe-dependent activation. The absolute amplitude of
proton-stimulated transient Na+ currents
(I ) of ASIC1a/2a
(squares), ASIC1a/2a + CFTR (circles), and
ASIC1a/2a + F508-CFTR (triangles) were plotted as a
function of the external pH from 4.0 to 7.5. The connected lines were
created by fitting data points with the Hill equation (see
"Experimental Procedures"). C, an alternative method to
calculate EC50 of pHe by fitting normalized
acid-gated Na+ currents
(I/Imax) with the modified Hill
equation, plotted against pHe. Holding potential = 60
mV.
|
|
CFTR Co-expression on Gating Behavior of ASIC1a/2a--
A further
question concerns the influence of CFTR on the kinetics of the
ASIC1a/2a channel. To address this issue, the time to peak current and
the inactivation time constants of ASIC1a/2a as functions of holding
potential and bath solution pH were examined. Fig.
6A demonstrates that there is
no difference in the time to peak current as a function of holding
potential from 100 mV to +100 mV in the presence or absence of CFTR.
Although the average time to peak current of ASIC1a/2a was decreased
from 408 ± 34 to 364 ± 17 ms by CFTR (between 60 mV and
+100 mV), this difference was not significant (p > 0.05). The summarized results for the inactivation time constants are
depicted in Fig. 6B. No significant change at any applied
voltage was observed.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of CFTR co-expression on gating
behavior of the heteromultimeric ASIC1a/2a channel. A,
times to peak current as a function of membrane potential
(Vm). The values of the time to peak current at each
potential in oocytes expressing ASIC1a/2a (squares) and
co-expressed with CFTR (circles) are plotted.
Numbers in parentheses are the number of oocytes.
B, i of ASIC1a/2a channel in the presence
(circles) or absence of CFTR (squares).
C, kinetics of activation behavior of ASIC1a/2a channel
stimulated as a function of pH (6.1-4.0). D, rates of
de-sensitization. The values of i for ASIC1a/2a
(squares) and ASIC1a/2a + CFTR (circles).
|
|
The absence of acid-gated Na+ currents in oocytes at
pHe 7.5 made it impossible to measure both the time to
Ip and inactivation time constant. Therefore, the
time to peak currents from the most acidic pHe of 4.0 to the
least acidic pHe of 6.1 were plotted in Fig. 6C
(n = 6). At pHe 4.0, the time to peak current
was 319 ± 22 and 308 ± 24 ms for ASIC1a/2a and ASIC1a/2a
co-expressed with CFTR, respectively. The time to peak current was not
changed significantly by CFTR co-expression at any pHe
(p > 0.05). The inactivation time constant of the
ASIC1a/2a channel exhibited a minimal pHe dependence and was
unchanged in the presence of CFTR (Fig. 6D).
It appears that in oocytes co-expressing ASIC1a/2a and CFTR,
i was pHe-dependent and that this was
not the case for the heteromultimeric ASIC1a/2a channels expressed in
the absence of CFTR (whereas the inactivation time constant was
uninfluenced by CFTR co-expression). The inactivation time constants
were 938 ± 161 and 1222 ± 86 ms for ASIC1a/2a and
co-expressed with CFTR, respectively, at pHe 4.0 (p > 0.05).
Kinetics of Extracellular Sodium Interaction with Heteromultimeric
Channel--
The homomultimeric ASIC1a and ASIC2a channels and the
heteromultimeric ASIC1a/2a channel are permeant to Na+,
Li+, and Ca2+ (17, 22, 51). The
heteromultimeric ASIC1a/2a channel has distinctly different biophysical
and pharmacological features from homomultimeric ASIC1a and ASIC2a
channels (22). Thus, we tested the hypothesis that the kinetics of
extracellular sodium interaction with the ASIC1a/2a channel could be
affected by CFTR co-expression. This was examined by sampling
acid-gated Na+ currents from oocytes expressing ASIC1a/2a
plus and minus CFTR at various extracellular Na+
concentrations. As shown in Fig. 7, the
peak of the acid-activated transient Na+ current
(Ip) and the sustained Na+ current
(Is) levels are dependent on the external
[Na+]. The estimated Km obtained by
fitting the peak current (Fig. 7A) with the Michealis-Menten
function was 105 ± 13 and 166 ± 19 mM for
ASIC1a/2a and ASIC1a/2a + CFTR, respectively. These values are
statistically different (p < 0.05). Similarly, the
Km values calculated from the sustained
Na+ currents were 102 ± 13 and 164 ± 8 mM for ASIC1a/2a and ASIC1a/2a + CFTR, respectively, again
significantly different from one another (Fig. 7B,
p < 0.05). The time to peak and i were not affected by CFTR at various external [Na+] (Fig.
7C).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 7.
CFTR co-expression on kinetics of
extracellular Na+ interaction with ASIC1a/2a channel.
The holding potential is 60 mV. Extracellular proton concentration is
10 4 M. A, normalized acid-gated
transient Na+ currents evoked in the presence of a series
of external Na+ concentrations ranging from 0 to 96 mM in oocytes expressing heteromultimeric ASIC1a/2a channel
(squares) and co-expressed with CFTR (circles).
The normalized Ip was calculated as
I = Ip(0) Ip(Na), where
Ip(0) is the peak current in the absence of sodium,
and Ip(Na) is the peak current sampled in the
presence of different extraoocyte sodium. The data points are connected
with fitting curves drawn by the Michealis-Menten equation (see
"Experimental Procedures" for details). B, the
normalized sustained Na+ currents obtained with a range of
extraoocyte Na+. Calculation of normalized
Is and representation of the symbols are identical
to panel A. C, gating kinetics of ASIC1a/2a
channel as a function of external sodium
([Na+]e). Both times to peak (circles)
and inactivation time constants (squares) for ASIC1a/2a and
ASIC1a/2a + CFTR (inverted triangles for time to peak and
up-triangles for i) are presented in panel
C.
|
|
Intermolecular Cross-talk Requires Normal Structure--
To
address the issue of a possible intracellular sodium dependence of the
regulation of ASICs by CFTR, we co-expressed CFTR with a
gain-of-function mutant of ASIC2a, namely, G430F. As shown in Fig.
8, expression of G430F-ASIC2a alone
exhibited a constitutively activated inward Na+ current at
pHe 7.5. Application of acidic pHe (4.0) unmasked a
novel additional acid-sensitive Na+ conductance in 6 of 7 oocytes expressing G430F-ASIC2a. The acid-sensitive Na+
current associated with G430F-ASIC2a took up to 8 s to reach its
maximal activity and displayed no tendency to inactivate over the
observation period (10 s). The influence of CFTR on both the constitutively activated basal Na+ current and the
acid-sensitive component ( INa) are summarized in Fig. 8, C and D. In oocytes expressing
G430F-ASIC2a alone, the basal current (at a holding potential of 60
mV and pHe of 7.5) was 7490 ± 1018 nA
(n = 14). CFTR co-expression had no significant effect
on this current (mean, 9643 ± 1050 nA, n = 11;
p > 0.05). Likewise, CFTR had no effect on the
acid-sensitive component of G430F-ASIC2a ( 3825 ± 648 nA
versus 3541 ± 2158 nA, +CFTR; n = 6). Time to peak of the acid-gated current (for those without peak
current, it was calculated as time to stable) increased slightly to
6059 ± 1078 ms from 5278 ± 1169 ms (p > 0.05).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 8.
Co-expression of CFTR with the
gain-of-function mutant of ASIC1a, G430F. A,
constitutively activated Na+ current at neutral pH
(pHe 7.5), proton-activated Na+ current
(pHe 4.0), and the net proton-sensitive Na+
conductance ( INa) in a single oocyte
expressing G430F-ASIC1a. INa is the
difference of proton-induced Na+ current at pHe 7.5 and that at pHe 4.0. The scale for the abscissa is 2 s and
for the ordinate is 2 µA. These currents were recorded by switching
the holding potential from 0 to 60 mV while pHe 4.0 was being
superfused. B, whole-cell proton-gated Na+
currents in an oocyte co-expressing ASIC1a/2a with CFTR. The
experimental protocol, INa measurement, and
symbols are same as in panel A. C, constitutively
activated Na+ currents. Basal currents
(I ) with (G430F + CFTR) or
without (G430F) at neutral pHe. D, proton-sensitive
currents ( I ).
I was calculated based on
the values of INa.
|
|
Depolarization of Membrane Potential Induced by Acidic
pHe--
If CFTR co-expression increased the rate of positive
charge flowing through the heteromultimeric ASIC1a/2a channel, the
membrane potential should also be regulated by acidic pHe. This idea was tested in the current clamp mode using the same protocol for
acidic pHe application. The average resting membrane potential
of uninjected oocytes at pHe 7.5 was 43 ± 5 mV
(n = 10, 3 frogs) and 35 ± 2 mV
(n = 57, 11 frogs) for ASIC1a/2a-injected oocytes and
42 ± 2 mV (n = 38, 6 frogs, Fig.
9) for ASIC1a/2a + CFTR-injected oocytes.
As shown in Fig. 9C, the net change in the maximal
depolarized membrane potential ( Em) at
pHe 4.0 in oocytes co-expressing ASIC1a/2a with CFTR was
39 ± 3 mV (n = 6), significantly greater
(p < 0.05) than in oocytes expressing only ASIC1a/2a
(24 ± 1 mV, n = 6). The decay rate (2 s) of the membrane potential, calculated by fitting with a first order
exponential, paralleled the i of the ASIC1a/2a-associated,
acid-gated Na+ currents (1.5 s). These observations
indicate that there was a coupling between the proton-gated
Na+ current and the proton-induced depolarization of the
membrane potential, suggesting that the depolarization of membrane
potential resulted from the entry of positive charge carried by
Na+ through ASICs.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 9.
Depolarization of membrane potential
(Em) caused by extraoocyte acidification. Current
clamp technique was applied to digitize changes in the resting membrane
potential resulting from extracellular acidity (pHe 4.0).
A, H2O-injected oocyte. The line
under the potential trace
(E )
indicates the application of pHe 4.0. B,
representative potential trace
(E ) from an oocyte
expressing ASIC1a/2a (ASIC-associated). The
difference of the potential trace ( Em = E E ) of ASIC1a/2a
(Total) and the background noise recorded in
H2O-injected oocyte (A). C, potential
trace (E ) recorded in an
oocyte co-expressing ASIC1a/2a with CFTR and the net change
( Em = E E ) in membrane potential
caused by acidity. D, average membrane potentials. Maximal
depolarization of Em by acidic pH 4.0 in oocytes
injected with H2O (square), expressing ASIC1a/2a
(circles) and co-expressing ASIC1a/2a with CFTR
(triangles) are shown. The rate of decay of
Em depolarization for oocyte expressing ASIC1a/2a is
2104 ± 14 ms and 2177 ± 15 ms for ASIC1a/2a + CFTR.
|
|
 |
DISCUSSION |
The purpose of the present study was to examine the hypothesis
that CFTR may interact with other members of the ENaC/DEG superfamily, the ASICs. We co-expressed CFTR with ASIC1a and/or ASIC2a in
Xenopus oocytes, and the proton-gated Na+
currents were evaluated with the conventional two-electrode voltage clamp technique. Our results demonstrated that steady-state CFTR up-regulates ASIC1a/2a, which was opposite to the effect of CFTR on rat
ENaC (8). Taken together, our studies strongly suggest that the
cross-talk between CFTR and these ENaC/DEG family members is very specific.
Our immunolocalization results revealed that both CFTR and ASIC2a
channel proteins are co-expressed in hypothalamic neurons. These
observations are completely in agreement with previous studies demonstrating that mRNA for ASIC2a and CFTR are present in
hypothalamus (17, 37, 38). Although we did not immunolocalize CFTR and ASIC1a in the hypothalamus due to the lack of antibodies against ASIC1a, ASIC1a and ASIC2a are co-expressed in hypothalamus (for review,
see Ref. 17).
CFTR co-expression does not influence the ionic selectivity of the
ASIC1a/2a channel (Fig. 3). The reversal potentials (+30 mV) measured
in the presence or absence of CFTR co-expression were similar. The
measured reversal potentials are in agreement with the prediction of
the Goldman-Hodgkin-Katz equation for a highly
Na+-permeable cation channel
(PNa:PK = 8.8).
Based on the assumption of a physical protein-protein interactions
between CFTR and ASIC1a/2a, we tried to identify the ASIC subunit
involved in the functional cross-talk of CFTR and ASIC1a/2a. Our
results demonstrated that neither the homomultimeric ASIC1a channels
nor the homomultimeric ASIC2a channels functionally interact with
CFTR.
The opening of acid-gated channels has been proposed to be a
consequence of protonation of the channel protein. In the case of ASIC
channels, possible multiple protonation domains would be histidine
residues located in the extracellular loops. CFTR may alter this
process within the ASIC1a/2a channel by pHe. However, our study
does not support this idea. No changes were observed in the pHe
activation of ASIC1a/2a with CFTR co-expression (Fig. 6, B
and C). Furthermore, CFTR co-expression did not regulate the
kinetics of the heteromultimeric ASIC1a/2a channel. Apart from the
activation rate, which was regulated in a
pHe-dependent manner, the inactivation time
constant and the time to peak current were not
voltage-dependent, pHe-dependent, or
dependent on extracellular sodium (Figs. 6 and 7C). CFTR
co-expression, therefore, failed to modify the kinetics of protonation
of the heteromultimeric ASIC1a/2a channel.
Although CFTR co-expression did not alter the protonation of ASICs,
analysis of the kinetics of external Na+ interaction with
the heteromultimeric ASIC1a/2a channel revealed a decrease in
Na+ concentration required for activating half of the
maximal current (Fig. 7). The currents did not saturate at
Na+ concentrations between 0 and 100 mM. We did
not measure currents at higher Na+ concentrations because
the increase in solution osmolarity will change cell volume, which is
likely to activate ASICs, which are sensitive to mechanical stimuli
(17). The reason why CFTR increased Na+ interaction with
the ASIC1a/2a channel is unknown. CFTR may increase open probability
and ASIC expression.
ENaC expression in oocytes leads to an increased cytoplasmic sodium
concentration accompanied by a depolarized membrane potential due to
constitutive channel activity. We hypothesized that the crucial
determinant to the contrasting effects of CFTR on ENaCs and on ASICs
could be the resultant changes in membrane potential and cytosolic salt
concentration. However, the noninteraction of G430F-ASIC2a, and CFTR
ruled out this possibility (Fig. 8). These results also suggested,
because the active Na+ transport pathway
(Na+/K+-ATPase) could not keep pace with
passive Na+ leak (Na+ channel,
Na+/H+ antiporter, etc.), leading to
accumulation of cytosolic Na+ and depolarization of
membrane potential possibly accompanied by acidosis, CFTR would not
up-regulate ASICs to protect neuronal function. Little is known about
the mechanism of the gating behavior of the modified channel.
Recently, Nagel et al. (52) suggested that CFTR inhibition
of ENaC was nonspecific. They argue that the apparent interaction results from electrical artifacts produced by a variable access resistance (because of overexpression of CFTR) and an uncompensated electrode resistance. Large changes in membrane resistance caused by
CFTR and ASIC expression did not occur in our experiments because the
membrane resistance of injected oocytes was close to that of uninjected
oocytes in the absence of acidic pHe (~200 ). Thus, the
whole cell currents measured in our experiments were much less than the
minimum 50 µA/oocyte Nagel et al. (52) calculated that
would make voltage clamping problematic. Moreover, the series
resistance of the reference electrode, the agar bridges, and bath
solution totaled less than 1 k , again less than the 20 k assumed
by Nagel et al. (52). Thus, the total series resistance was
much less (<4%) than that of the membrane and could therefore not
introduce a significant error in voltage measurements. Even assuming
that overexpression of CFTR resulted in a change in the access
resistance and, thus, produced a significant voltage drop in the bath,
it cannot account for the opposite effects of CFTR on ENaCs and ASICs.
Therefore, the interaction between CFTR and ENaC/DEG is specific and
not due to an artifactual error resulting from an uncompensated series
and membrane resistance.
Divalent cations such as Ca2+ and Mg2+ can
modulate both ENaC and ASIC activity (17, 29, 49, 53-55). Recently, de
Weille and Bassilana (49) showed that external Ca2+
regulated ASIC1a and ASIC2a differently. Furthermore, intracellular Ca2+ only affected ASIC1a. CFTR significantly up-regulates
ASICs at a pHe more acidic than 5.5 (Fig. 5B) in
contrast to the effects of Ca2+ on ASICs, which is only
evident at pHe 7.0 (55). Therefore, the up-regulation of ASICs
by CFTR is unlikely due to an increase in cytoplasmic Ca2+
because the effects of cytoplasmic Ca2+ and the regulation
of CFTR on the homomultimeric ASIC1a and ASIC2a channels and the
heteromultimeric ASIC1a/2a channel are not the same (49).
Even in the case of CFTR regulation of ENaC, diverse observations have
been documented in epithelial tissues. The epithelial Na+
channel located in the apical membrane is activated in airway, lung,
intestinal, renal epithelia, and in heterologous expression systems
(for review, see Refs. 13-16). In contrast, ENaC function depends
critically on the state of CFTR in a purely salt-absorbing epithelium,
and ENaC cannot be activated in cystic fibrosis sweat gland ducts where
CFTR is defective or absent (56). Moreover, the effect of ENaC
overexpression on CFTR in the Xenopus oocytes (8, 10) is
also different from that observed in mouse endometrial epithelium (57).
One explanation for these diverse observations between CFTR and ENaC is
that it is due to variant forms of ENaC and CFTR. Alternatively,
different accessory components that operate in different cellular
systems may underlie these differential effects (56). But the puzzle is
still unresolved. Although ASICs are members of the ENaC/DEG family,
there are differences in the biophysical and pharmacological
characteristics between ENaC and ASIC, including their molecular
sequence, cation selectivity, the unitary conductance, gating behavior,
sensitivity to amiloride, etc. Furthermore, their responses to
regulators or modulators (for example, protons, Ca2+,
Mg2+, Na+, neuropeptides, monocarboxylic acids,
inflammation, global ischemia, etc.) are different, even opposite (for
review, see Refs. 17 and 58). The possibility that the diverse function
and regulation between ASICs and ENaC may also contribute to their
different interactions with CFTR has not been tested.
Our observations that wild type but not F508-CFTR up-regulated the
ASIC1a/2a channel augment the idea that CFTR, functioning as a
regulator of a plethora of plasma membrane transporters, may also
interact with neuronal membrane proteins. In the central nervous system
(CNS), the function of ASICs is still hypothetical. The primary
function of ASICs in the central nervous system may be to detect pH
drops in brain tissue produced by release of neurotransmitters under
physiological conditions participating in the regulation of synaptic
activity and in pathophysiological conditions, such as cerebral
ischemia, seizure, epilepsy, and trauma, where a reduction of tissue pH
occurs. Up-regulation of ASICs by CFTR implies that in cystic fibrosis,
the relative attenuation of ASICs in brain is less sensitive to pH
changes in the absence of normal CFTR. In addition, CFTR itself
regulates proton transmembrane transport and, therefore, modulates
synaptic activity (13, 16). Because ASICs may also respond to other
stimuli, including Phe-Met-Arg-Phe-amide and other
neuromodulatory substances (32), up-regulation of ASICs by CFTR can
contribute to the motor and sensory neuronal function, for example,
modulation of nociceptive synaptic transmission (i.e. pain,
a most common symptom of cystic fibrosis) by altering central
sensitization (59). ASICs may function as one component of oxygen
sensors in combination with K+,Cl channels in
O2-sensing and acid-sensing neurons based on the hypothesis
that the response to oxygen requires multiple sensors and they work
together to shape the overall sensory response of brain neurons over a
wide range of arterial oxygen tensions (50). Thus, the interactions of
CFTR and ASICs indicate that brain neuropathophysiology in cystic
fibrosis patients may be related to a depression of ASICs function in
the presence and absence of extracellular acidosis.
Our observations demonstrate that activity of the heteromultimeric
ASIC1a/2a channel is up-regulated in the presence of CFTR when
co-expressed in Xenopus oocytes at least in part by
modifying the interaction with extraoocyte sodium. The physiological
relevance in the context of native tissues remains to be explored.
 |
ACKNOWLEDGEMENTS |
We thank Eddie Walthall and Drs. Eric J. Sorscher and Kevin K. Kirk (University of Alabama at
Birmingham Cystic Fibrosis Research Center) for technical support and
helpful comments.
 |
FOOTNOTES |
*
This study was supported by National Institutes of Health
Grants DK53468, DK56095, and DK34533 and the Cystic Fibrosis
Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Pharmacology, University of Washington,
Seattle, WA 98195.
To whom correspondence should be addressed: Dept. of
Physiology and Biophysics, The University of Alabama at Birmingham,
1918 University Blvd., MCLM 704, Birmingham, AL 35294-0005. Tel.:
205-934-6220; Fax: 205-934-2377; E-mail:
benos@physiology.uab.edu.
Published, JBC Papers in Press, December 17, 2001, DOI 10.1074/jbc.M109465200
 |
ABBREVIATIONS |
The abbreviations used are:
ENaC, epithelial
sodium channel;
CF, cystic fibrosis;
CFTR, CF transmembrane conductance
regulator;
, ohm;
ASIC, acid-sensitive ion channel;
MES, 4-morpholineethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Boucher, R. C.,
Cotton, C. U.,
Gatzy, J. T.,
Knowles, M. R.,
and Yankaskas, J. R.
(1988)
J. Physiol.
405,
77-103[Abstract/Free Full Text]
|
| 2.
|
Knowles, M. R.,
Gatzy, J. T.,
and Boucher, R. C.
(1981)
N. Engl. J. Med.
341,
156-162[Abstract/Free Full Text]
|
| 3.
|
Mall, M.,
Bleich, M.,
Greger, R.,
Schreiber, R.,
and Kunzelmann, K.
(1998a)
J. Clin. Invest.
102,
15-21[Medline]
[Order article via Infotrieve]
|
| 4.
|
Mall, M.,
Bleich, M.,
Greger, R.,
Schürlein, M.,
Kühr, J.,
Seydewitz, H. H.,
Brandis, M.,
and Kunzelmann, K.
(1998b)
Am. J. Physiol.
275,
G1274-G1281[Abstract/Free Full Text]
|
| 5.
|
Mall, M.,
Bleich, M.,
Kuehr, J.,
Brandis, M.,
Greger, R.,
and Kunzelmann, K.
(1999)
Am. J. Physiol.
277,
G709-G816[Abstract/Free Full Text]
|
| 6.
|
Stutts, M. J.,
Canessa, C. M.,
Olsen, J. C.,
Hamrick, M.,
Cohn, J. A.,
Rossier, B. C.,
and Boucher, R. C.
(1995)
Science
269,
847-850[Abstract/Free Full Text]
|
| 7.
|
Tabcharani, J. A.,
Rommens, J. M.,
Hou, Y.-X.,
Chang, X.-B.,
Tsui, L. C.,
Riordan, J. R.,
and Hanrahan, J. W.
(1993)
Nature
366,
79-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Ji, H.-L.,
Chalfant, M. L.,
Jovov, B.,
Lockhart, J. P.,
Parker, S. B.,
Fuller, C. M.,
Stanton, B. A.,
and Benos, D. J.
(2000)
J. Biol. Chem.
275,
27947-27956[Abstract/Free Full Text]
|
| 9.
|
Mall, M.,
Hipper, A.,
Greger, R.,
and Kunzelmann, K.
(1996)
FEBS Lett.
381,
47-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Chabot, H.,
Vives, M. F.,
Dagenais, A.,
Grygorczyk, C.,
Berthiaume, Y.,
and Grygorczyk, R.
(1999)
J. Membr. Biol.
169,
175-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Johnson, L. G.,
Boyles, S. E.,
Wilson, J.,
and Boucher, R. C.
(1995)
J. Clin. Invest.
95,
1377-1382
|
| 12.
|
Konstas, A. A.,
Bielfeld-Ackermann, A.,
and Korbmacher, C.
(2001)
Pfluegers Arch. Eur. J. Physiol.
442,
752-761[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kunzelmann, K.,
Schreiber, R.,
Nitschke, R.,
and Mall, M.
(2000)
Pfluegers Arch.
440,
193-201[Medline]
[Order article via Infotrieve]
|
| 14.
|
Kunzelmann, K.
(2001)
News Physiol. Sci.
16,
167-170[Abstract/Free Full Text]
|
| 15.
|
Kunzelmann, K.,
Schreiber, R.,
and Boucherot, A.
(2001)
Kidney Int.
60,
455-461[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Schwiebert, E. M.,
Benos, D. J.,
Egan, M. E.,
Stutts, M. J.,
and Guggino, W. B.
(1999)
Physiol. Rev.
79,
S145-S166
|
| 17.
|
Waldmann, R.,
Champigny, G.,
Lingueglia, E.,
de Weille, J. R.,
Heurteaux, C.,
and Lazdunski, M.
(1999)
Ann. N. Y. Acad. Sci.
868,
67-76[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Awayda, M. D.,
Boudreaux, M. J.,
Reger, R. L.,
and Hamm, L. L.
(2000)
Am. J. Physiol. Cell Physiol.
279,
1896-1905
|
| 19.
|
Leaf, A.,
Keller, A.,
and Dempsey, F. F.
(1964)
Am. J. Physiol.
207,
547-552
|
| 20.
|
Coscoy, S.,
Lingueglia, E.,
Lazdunski, M.,
and Barbry, P.
(1998)
J. Biol. Chem.
273,
8317-8322[Abstract/Free Full Text]
|
| 21.
|
Lingueglia, E.,
de Weille, J. R.,
Bassilana, F.,
Heurteaux, C.,
Sakai, H.,
Waldmann, R.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
29778-29783[Abstract/Free Full Text]
|
| 22.
|
Bassilana, F.,
Champigny, G.,
Waldmann, R.,
de Weille, J. R.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
28819-28822[Abstract/Free Full Text]
|
| 23.
|
García-Añoveros, J.,
Derfler, B.,
Neville-Golden, J.,
Hyman, B. T.,
and Corey, D. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1459-1464[Abstract/Free Full Text]
|
| 24.
|
Waldmann, R.,
Champigny, G.,
Bassilana, F.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
Nature
386,
173-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Price, M. P.,
Snyder, P. M.,
and Welsh, M. J.
(1996)
J. Biol. Chem.
271,
7879-7882[Abstract/Free Full Text]
|
| 26.
|
Waldmann, R.,
Champigny, G.,
Voilley, N.,
Lauritzen, I.,
and Lazdunski, M.
(1996)
J. Biol. Chem.
271,
10433-10436[Abstract/Free Full Text]
|
| 27.
|
Champigny, G.,
Voilley, N.,
Waldmann, R.,
and Lazdunski, M.
(1998)
J. Biol. Chem.
273,
15418-15422[Abstract/Free Full Text]
|
| 28.
|
Ugawa, S.,
Minami, Y.,
Guo, W.,
Saishin, Y.,
Takatsuji, K.,
Yamamoto, T.,
Tohyama, M.,
and Shimada, S.
(1998)
Nature
395,
555-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Chen, C. C.,
England, S.,
Akopian, A. N.,
and Wood, J. N.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10240-10245[Abstract/Free Full Text]
|
| 30.
|
de Weille, J. R.,
Bassilana, F.,
Lazdunski, M.,
and Waldmann, R.
(1998)
FEBS Lett.
433,
257-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Waldmann, R.,
Bassilana, F.,
de Weille, J.,
Champigny, G.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
20975-20978[Abstract/Free Full Text]
|
| 32.
|
Babinski, K., Le, K. T.,
and Seguela, P.
(1999)
J. Neurochem.
72,
51-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Ishibashi, K.,
and Marumo, F.
(1998)
Biochem. Biophys. Res. Commun.
245,
589-593[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Grunder, S.,
Geissler, H. S.,
Bassler, E. L.,
and Ruppersberg, J. P.
(2000)
Neuroreport
11,
1607-1611[Medline]
[Order article via Infotrieve]
|
| 35.
|
Akopian, A. N.,
Chen, C. C.,
Ding, Y.,
Cesare, P.,
and Wood, J. N.
(2000)
Neuroreport
11,
2217-2222[Medline]
[Order article via Infotrieve]
|
| 36.
|
Mulberg, A. E.,
Wiedner, E. B.,
Bao, X.,
Marshall, J.,
Jefferson, D. M.,
and Altschuler, S. M.
(1994)
Neuroreport
5,
1684-1688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Mulberg, A. E.,
Resta, L. P.,
Wiedner, E. B.,
Altschuler, S. M.,
Jefferson, D. M.,
and Broussard, D. L.
(1995)
J. Clin. Invest.
96,
646-652
|
| 38.
|
Johannesson, M.,
Bogdanovic, N.,
Nordqvist, A. C.,
Hjelte, L.,
and Schalling, M.
(1997)
Neuroreport
8,
535-539[Medline]
[Order article via Infotrieve]
|
| 39.
|
Xu, Z.,
Gupta, V.,
Lei, D.,
Holmes, A.,
Carlson, E.,
and Gruenert, D. C.
(1998)
Gene (Amst.)
211,
117-123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Ueno, S.,
Nakaya, T.,
and Akaike, N.
(1992)
J. Physiol.
447,
309-327[Abstract/Free Full Text]
|
| 41.
|
Mulberg, A. E.,
Weyler, R. T.,
Altschuler, S. M.,
and Hyde, T. M.
(1998)
Neuroreport
9,
141-144[Medline]
[Order article via Infotrieve]
|
| 42.
|
Weyler, R. T.,
Yurko-Mauro, K. A.,
Rubenstein, R.,
Kollen, W. J.,
Reenstra, W.,
Altschuler, S. M.,
Egan, M.,
and Mulberg, A. E.
(1999)
Am. J. Physiol.
277,
C563-C571[Abstract/Free Full Text]
|
| 43.
|
Wetsel, W. C.,
Eraly, S. A.,
Whyte, D. B.,
and Mellon, P. L.
(1993)
Endocrinology
132,
2360-2370[Abstract/Free Full Text]
|
| 44.
|
Jovov, B.,
Ismailov, I. I.,
Berdiev, B. K.,
Fuller, C. M.,
Sorscher, E. J.,
Dedman, J. R.,
Kaetzel, M. A.,
and Benos, D. J.
(1995)
J. Biol. Chem.
270,
29194-29200[Abstract/Free Full Text]
|
| 45.
|
Demolombe, S.,
Baro, I.,
Bebok, Z.,
Clancy, J. P.,
Sorscher, E. J.,
Thomas-Soumarmon, A.,
Pavirani, A.,
and Escande, D.
(1996)
Gene Ther.
3,
685-694[Medline]
[Order article via Infotrieve]
|
| 46.
|
Ji, H.-L.,
Parker, S.,
Langloh, A. L.,
Fuller, C. M.,
and Benos, D. J.
(2001)
Am. J. Physiol. Cell Physiol.
281,
64-74
|
| 47.
|
Kuruma, A.,
Hirayama, Y.,
and Hartzell, H. C.
(2000)
Am. J. Physiol. Cell Physiol.
279,
1401-1413
|
| 48.
|
Escoubas, P.,
de Weille, J. R.,
Lecoq, A.,
Diochot, S.,
Waldmann, R.,
Champigny, G.,
Moinier, D.,
Menez, A.,
and Lazdunski, M.
(2000)
J. Biol. Chem.
275,
25116-25121[Abstract/Free Full Text]
|
| 49.
|
de Weille, J.,
and Bassilana, F.
(2001)
Brain Res.
900,
277-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Prabhakar, N. R.,
and Overholt, J. L.
(2000)
Respir. Physiol.
122,
209-221[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Coscoy, S.,
de Weille, J. R.,
Lingueglia, E.,
and Lazdunski, M.
(1999)
J. Biol. Chem.
274,
10129-10132[Abstract/Free Full Text]
|
| 52.
|
Nagel, G.,
Szellas, T.,
Riordan, J. R.,
Friedrich, T.,
and Hartung, K.
(2001)
EMBO Rep.
2,
249-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Ishikawa, T.,
Marunaka, Y.,
and Rotin, D.
(1998)
J. Gen. Physiol.
111,
825-846[Abstract/Free Full Text]
|
| 54.
|
Berdiev, B. K.,
Mapstone, T. B.,
Markert, J. M.,
Gillespie, G. Y.,
Lockhart, J.,
Fuller, C. M.,
and Benos, D. J.
(2001)
J. Biol. Chem.
276,
38755-38761[Abstract/Free Full Text]
|
| 55.
|
Immke, D. C.,
and McCleskey, E. W.
(2001)
Nat. Neurosci.
4,
869-870[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Reddy, M. M.,
Light, M. J.,
and Quinton, P. M.
(1999)
Nature
402,
301-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Chan, L. N.,
Wang, X. F.,
Tsang, L. L.,
Liu, C. Q.,
and Chan, H. C.
(2000)
Biochem. Biophys. Res. Commun.
276,
40-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Garty, H.,
and Palmer, L. G.
(1997)
Physiol. Rev.
77,
359-396[Abstract/Free Full Text]
|
| 59.
|
Woolf, C. J.,
and Salter, M. W.
(2000)
Science
288,
1765-1768[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-L. Ji, W. Song, Z. Gao, X.-F. Su, H.-G. Nie, Y. Jiang, J.-B. Peng, Y.-X. He, Y. Liao, Y.-J. Zhou, et al.
SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms
Am J Physiol Lung Cell Mol Physiol,
March 1, 2009;
296(3):
L372 - L383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Su, Q. Li, K. Shrestha, E. Cormet-Boyaka, L. Chen, P. R. Smith, E. J. Sorscher, D. J. Benos, S. Matalon, and H.-L. Ji
Interregulation of Proton-gated Na+ Channel 3 and Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem.,
December 1, 2006;
281(48):
36960 - 36968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Donier, F. Rugiero, K. Okuse, and J. N. Wood
Annexin II Light Chain p11 Promotes Functional Expression of Acid-sensing Ion Channel ASIC1a
J. Biol. Chem.,
November 18, 2005;
280(46):
38666 - 38672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Price, R. J. Thompson, J. O. Eshcol, J. A. Wemmie, and C. J. Benson
Stomatin Modulates Gating of Acid-sensing Ion Channels
J. Biol. Chem.,
December 17, 2004;
279(51):
53886 - 53891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Ji and D. J. Benos
Degenerin Sites Mediate Proton Activation of {delta}{beta}{gamma}-Epithelial Sodium Channel
J. Biol. Chem.,
June 25, 2004;
279(26):
26939 - 26947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Askwith, J. A. Wemmie, M. P. Price, T. Rokhlina, and M. J. Welsh
Acid-sensing Ion Channel 2 (ASIC2) Modulates ASIC1 H+-activated Currents in Hippocampal Neurons
J. Biol. Chem.,
April 30, 2004;
279(18):
18296 - 18305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Agopyan, J. Head, S. Yu, and S. A. Simon
TRPV1 receptors mediate particulate matter-induced apoptosis
Am J Physiol Lung Cell Mol Physiol,
March 1, 2004;
286(3):
L563 - L572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Ji, L. R. Bishop, S. J. Anderson, C. M. Fuller, and D. J. Benos
The Role of Pre-H2 Domains of {alpha}- and {delta}-Epithelial Na+ Channels in Ion Permeation, Conductance, and Amiloride Sensitivity
J. Biol. Chem.,
February 27, 2004;
279(9):
8428 - 8440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.C. Boucher
New concepts of the pathogenesis of cystic fibrosis lung disease
Eur. Respir. J.,
January 1, 2004;
23(1):
146 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Baron, E. Deval, M. Salinas, E. Lingueglia, N. Voilley, and M. Lazdunski
Protein Kinase C Stimulates the Acid-sensing Ion Channel ASIC2a via the PDZ Domain-containing Protein PICK1
J. Biol. Chem.,
December 20, 2002;
277(52):
50463 - 50468.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|